Small biotech trials face hidden supply risks that waste up to 75% of materials, delay timelines, and drain funding faster. Learn what causes them and how to prevent them.
- The RTSM–EDC Integration Trap: Why Broken Workflows Still Undermine Trial Execution
- Building Win-Win Partnerships In Clinical Trial Supply
- The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early
- Bridging Preclinical Science And Trial Supply Success
- The New Reality Of Clinical Trial Logistics
- Drug Shortages In Clinical Trials: A Policy Blueprint
- Leading Clinical Trial Supply Teams: Insights And Best Practices
- Designing Clinical Trials For Hard-To-Access Patients
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
CDMO Support: Success In Early-Phase Drug Product Development
As sponsors strive to deliver therapies with increasing efficiency, CDMOs are poised to remain vital, offering specialized expertise, accelerated timelines, cost efficiency, and risk mitigation.
-
7 Key Considerations For Designing The Optimal IRT/RTSM
Sponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.
-
Key Considerations For Selecting Flexible Fillers
Flexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
Investigational Medicinal Products: Labeling Changes And Their Implications
Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
Complex Randomization Delivered Successfully
Learn about the strategy and successful execution of a complex randomization design that helped LG Chem overcome its clinical trial challenges alongside eClinical randomization experts.
-
Critical Requirements In Sourcing Comparator Drugs
Sourcing comparator drugs has become complex in the clinical supply chain. As a result, clinical trial sponsors and pharma companies are eager to identify opportunities to overcome these challenges.
-
Is Your Clinical Supply Chain Fully Optimized?
Streamlined supply chain operations alleviate staff workload and significantly reduce IP waste. With the right partners, you can create a fully optimized, cost-effective supply chain strategy.
-
Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch
Tech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.
-
Web-Based CDR System: Precision Without Compromise
Validated research confirms that web-based cognitive testing maintains the millisecond precision of traditional hardware, ensuring high-quality data for decentralized clinical trials.
-
Overcoming The Challenge Of Maintaining Sterility At Low Temperature Storage
Learn about a biotech company with a recently approved gene therapy product that needed to select a packaging solution to meet their needs for storage at low temperatures and still get to market quickly.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.